Discounted Cash Flow (DCF) Analysis Unlevered

KORU Medical Systems, Inc. (KRMD)

$3.39

0.00 (0.00%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 3.39 | undervalue

Operating Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 15.4417.3523.1624.1823.4926.2729.3932.8736.7641.12
Revenue (%)
EBITDA 1.521.491.04-0.78-2.300.520.580.650.730.81
EBITDA (%)
EBIT 1.221.180.70-1.19-2.760.050.060.060.070.08
EBIT (%)
Depreciation 0.300.310.340.420.460.470.520.590.650.73
Depreciation (%)

Balance Sheet Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 3.585.265.8727.3225.3315.7417.6119.7022.0324.64
Total Cash (%)
Account Receivables 1.671.433.232.574.313.263.644.084.565.10
Account Receivables (%)
Inventories 1.352.102.396.836.114.495.025.626.287.03
Inventories (%)
Accounts Payable 0.770.450.570.621.230.941.051.181.321.47
Accounts Payable (%)
Capital Expenditure -0.42-0.48-0.43-1.06-0.35-0.69-0.77-0.87-0.97-1.08
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 3.39
Beta 0.346
Diluted Shares Outstanding 44.39
Cost of Debt
Tax Rate -65.25
After-tax Cost of Debt -%
Risk-Free Rate
Market Risk Premium
Cost of Equity 5.176
Total Debt 0.10
Total Equity 150.47
Total Capital 150.56
Debt Weighting 0.06
Equity Weighting 99.94
Wacc

Build Up Free Cash

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 15.4417.3523.1624.1823.4926.2729.3932.8736.7641.12
EBITDA 1.521.491.04-0.78-2.300.520.580.650.730.81
EBIT 1.221.180.70-1.19-2.760.050.060.060.070.08
Tax Rate 32.29%22.63%18.96%1.49%-65.25%2.03%2.03%2.03%2.03%2.03%
EBIAT 0.820.910.56-1.18-4.560.050.060.060.070.08
Depreciation 0.300.310.340.420.460.470.520.590.650.73
Accounts Receivable -0.25-1.810.66-1.741.05-0.39-0.43-0.48-0.54
Inventories --0.75-0.28-4.440.721.62-0.53-0.59-0.67-0.74
Accounts Payable --0.320.120.050.60-0.290.110.120.140.16
Capital Expenditure -0.42-0.48-0.43-1.06-0.35-0.69-0.77-0.87-0.97-1.08
UFCF 0.71-0.08-1.50-5.55-4.862.21-1-1.12-1.25-1.40
WACC
PV UFCF -----
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) -
Free cash flow (t + 1) -1.43
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -25.24
Equity Value -
Shares Outstanding 44.39
Equity Value Per Share -